| 000 | 01339 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511213047.0 | ||
| 264 | 0 | _c19911105 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReitz, M | |
| 245 | 0 | 0 |
_aIncreasing alkaline DNase activity with substrate specificity for denaturated DNA after high dose methotrexate therapy. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _cJun 1991 |
||
| 300 |
_a656-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBone Marrow _xmetabolism |
| 650 | 0 | 4 | _aBone Marrow Cells |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDeoxyribonucleases _xmetabolism |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aIsoelectric Focusing |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aMagnesium _xpharmacology |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aNucleic Acid Hybridization |
| 650 | 0 | 4 |
_aOsteosarcoma _xmetabolism |
| 650 | 0 | 4 | _aPhytohemagglutinins |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aThymidine _xmetabolism |
| 700 | 1 | _aGutjahr, P | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 41 _gno. 6 _gp. 656-9 |
|
| 999 |
_c1936554 _d1936554 |
||